Typhoid vaccine Vi conjugate costeffective in various settingsPharmacoEconomics & Outcomes News -doi:10.1007/s40274-018-4780-yNoneSpringer International PublishingPharmacoeconomics & Outcomes News
Incorporating herd protection into a cost-benefit analysis of typhoid fever vaccine interventionsAntillon, MPitzer, V E
Cost-effectiveness of using environmental surveillance to target the roll-out typhoid conjugate vaccinedoi:10.1016/j.vaccine.2019.12.061Brittany L. Hagedorn aJillian Gauld aNicholas Feasey bHao Hu aElsevier BVVaccine